MYOTAN

This brand name is authorized in Nigeria. It is also authorized in Singapore.

Active ingredients

The drug MYOTAN contains one active pharmaceutical ingredient (API):

1
UNII 3ST302B24A - LOSARTAN POTASSIUM
 

Losartan is a synthetic oral angiotensin-II receptor (type AT1) antagonist. Antihypertensive activity and suppression of plasma aldosterone concentration are maintained, indicating effective angiotensin II receptor blockade.
 
Read more about Losartan

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
C4-0341 Tablet Myotan 50 Tablets TAB 50 mg Each tablet contains: Losartan Potassium 50 mg 20/12/2019

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C09CA01 Losartan C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain
Discover more medicines within C09CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database C4-0341
SG Health Sciences Authority 14475P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈